Are you about to leave millions on the table?

In 5 minutes, you can see how your company stacks up against what buyers pay a premium for and where valuation gaps may be hiding.

We’ve compiled the top 5 benchmarks for healthtech and pharmacy CEOs preparing for a future exit, whether that’s 12, 24, or 36 months away.

5-7 minute assessment

Instant visual breakdown

Benchmarked against real exits

Get my Exit Readiness Scorecard

If you’re a founder or PE ownership group, you might be:

Concerned buyers will misunderstand or oversimplify your business

Worried a blind spot in your growth strategy will surface during diligence

Afraid you’ll regret the exit terms if your pitch falls short

Strong revenue and loyal customers are not enough. Buyers don‘t pay for innovation alone. They pay for clarity, credibility, and proof that your business is built to scale.

Even category leaders and companies with strong EBITDA margins get discounted when their story is fragmented or unclear.
Buyers form a valuation opinion long before they ever see your financials. They judge the clarity of your story first.
If your positioning is fuzzy, your messaging is fragmented, or your organization's impact is unclear, you're leaving money on the table.

Where are you now?

These are the three most common challenges healthtech and pharmacy leaders face before a premium exit.

01

Your story isn’t clear enough.

Buyers misunderstand your value, or the narrative no longer reflects the business you’ve built.

You've built something powerful, but when you describe it to potential buyers or investors, they don’t immediately see the full picture. Your positioning feels outdated, your messaging is inconsistent across channels, and your team struggles to articulate why customers choose you.

Exit Readiness Sprint

02

Your investor narrative isn’t premium yet.

You want buyers to see your worth, package proof, and create competitive tension.

You’re preparing for an exit or fundraise, but your materials don’t command the premium you deserve. Your operational performance is strong, but it's not packaged in a way that creates urgency or competitive tension among potential acquirers.

Premium Acquisition Sprint

03

Your growth engine isn’t predictable.

You want stronger revenue quality, valuation metrics, and a scalable commercial system.

Revenue is growing, but it's inconsistent or dependent on a few large customers. You need to build repeatable demand generation systems, improve margin quality, and strengthen the metrics that buyers actually reward with higher multiples.

Growth Engine Partnership

Not sure which situation you are in?

LDNA has a structured path to elevate your value and strengthen your position in the market.

Turn noise into negotiating power

Legacy DNA specializes solely in commercialization,
valuation strategy, and brand transformation for
healthtech and pharmacy leaders. We help you build a
defensible market position that earns premium multiples.

Why Legacy DNA?

Every healthtech and pharmacy organization has a unique commercial DNA — the underlying structure of its value story, customer impact, differentiation, and growth potential. Most companies never fully unlock it.

We go inside the business to uncover how it works, where value is created, and what buyers need to believe. Then we help leadership teams articulate that story with the clarity, confidence, and proof buyers expect.

The result is commercialization with purpose: stronger valuation,
lasting impact, and a go-to-market story that holds up long after
the deal closes.

Learn more about our firm

When you reveal the true why behind the business, you build a legacy that lasts.

Growth that compounds into valuation

“We had something good. Legacy DNA made it better — and then some.”

— Dr. Stephen Vogt, Founder & Former CEO of BioPlus Specialty Pharmacy

When BioPlus partnered with Legacy DNA, they were respected but overlooked in a crowded specialty pharmacy market.

Consecutive
quarters of growth

$750M
→ $2B

Revenue Growth

+202%

Gross profit increase

Premium exits:
Nautic Partners →
Elevance Health

Read this billion-dollar growth story

Let’s write your exit story together.

Schedule a strategic fit call →

Article

What makes a healthtech legend?

Here are three traits that instantly separate healthtech legends from the rest and command premium multiples.

The #1 reason healthtech companies fail to scale

High burn isn’t momentum; it’s fragility. See how efficient growth drives higher multiples.

Five hard truths exit buyers won’t tell you

Most CEOs lose millions because they don’t see what buyers really value.

Get your Exit Readiness Scorecard

If you’re preparing for a future exit, your brand clarity, market position, and growth story can make or break your valuation. The Exit Readiness Scorecard™ reveals where you’re strong, where you're vulnerable, and what to fix before you enter the deal room.

Takes 5-7 minutes

10 questions across 5 valuation domains

Instant score with visual breakdown

Benchmarked against real exits and acquisition standards

Built for healthtech and pharmacy leaders

Start my Exit Readiness Scorecard

Are you about to leave millions on the table?

Great health companies
get undervalued every day.

Speed. Clarity. Impact.

Speed

Clarity

Impact